EIF3A and cancer: We have also found in the previous study (Liu et al., 2011) that a selected cisplatin-sensitive cell line expressed a higher level of eIF3a compared with the parent cell line, suggesting that cancer cells may alter eIF3a expression to adapt to a DNA-damaging environment by regulating DNA damage repair protein synthesis.